Content about Goldman Sachs

April 8, 2013
Safeway hoping to raise as much as $220 million through Blackhawk IPO

Blackhawk Network Holdings announced its intent to open its initial public offering of 10 million shares at an estimated offering price of $20 to $22 per share.

February 11, 2013
Mylan appoints two new board members

Mylan has appointed its president and a former partner at Goldman Sachs to its board of directors, the generic drug maker said.

January 4, 2013
Bloomberg: B&L on sales block for as much as $10 billion

According to a Bloomberg report, Abbott Laboratories, Johnson & Johnson and Sanofi are all potential suitors for Bausch & Lomb's eye care business in a deal that could be valued as high as $10 billion.

December 21, 2012
Watson to present at Goldman Sachs, J.P. Morgan healthcare conferences

Watson Pharmaceuticals will present at two conferences sponsored by financial banks, the company said.

September 18, 2012
Valeant's finance chief joins board

Valeant Pharmaceuticals CFO Howard Schiller has been appointed to the drug maker's board of directors.

September 11, 2012
Walgreens announces pricing of senior notes

Walgreens on Monday announced that it has priced an underwritten public offering of senior notes.

September 6, 2012
Safeway outlines three future growth platforms: Wellness, loyalty and fuel

Safeway will package $150 million in real healthcare savings into an overall wellness strategy to be implemented over the course of 2013, the grocer's chairman and CEO Steve Burd told analysts Thursday morning at the Goldman Sachs 19th Annual Global Retailing Conference.

March 14, 2012
A&P emerges from Chapter 11

Grocer A&P has emerged from bankruptcy as a privately held company.

November 11, 2011
Valeant names CFO

A former Goldman Sachs executive will join Valeant Pharmaceuticals as EVP and CFO.

July 15, 2011
Clorox receives acquisition proposal from Icahn Enterprises

Clorox on Friday confirmed it has received an unsolicited conditional proposal from Icahn Enterprises to acquire the company for $76.50 per share, subject to due diligence, financing and other conditions.

April 1, 2011
GNC announces IPO

GNC Thursday evening announced its initial public offering of 22.5 million shares of its Class A common stock at an opening price of $16 per share.

July 22, 2010
Report: Carlyle to sell Philosophy skin care business

Private equity firm Carlyle Group is reportedly looking to sell skin care company Philosophy for...

© 2013 Drug Store News. All Rights Reserved.